EIN: 463392458
UEI: PMCCG3JWP285
Audited by: Roslund, Prestage & Company, P.C.
Oversight agency: 93 [Department of Health and Human Services]
View federal awards & risk assessment →
Data as of September 7, 2026
Management decision deadline — for entities that funded this organization
The FAC accepted this audit on June 23, 2026. Under 2 CFR 200.521(d), a pass-through entity that provided federal funds to this organization for this audit period must issue a management decision on these findings by December 23, 2026 (105 days from today).
What is a management decision? →FAC accepted this audit on May 1, 2025 — management decision was due November 1, 2025.
FAC accepted this audit on April 4, 2024 — management decision was due October 4, 2024.
FAC accepted this audit on April 13, 2023 — management decision was due October 13, 2023.
During testing of amounts charged to the grants it was noted that provider stabilization payments were charged to the Treatment and Women?s Specialty Services grants but were not authorized by the grants. Cause/Effect: This condition appears to be the result of a misunderstanding of costs allowed under this grant. These costs were not in compliance with 2 CFR 200.402. Questioned Cost: $289,629 (Treatment and Access Management: $275,928, Women?s Specialty Services: $13,701). Recommendation: We recommend that the Entity review all grant agreements to gain a thorough understanding of allowable costs and then establish/modify internal controls to assure that only allowable costs are charged to the grant. View of Responsible Official: Management is in agreement with this recommendation
Show full finding ▾Hide full finding ▴2022-001: Considered a significant deficiency in internal control/immaterial non-compliance Program: ALN 93.959 Block Grants for Prevention and Treatment of Substance Abuse (Treatment and Access Management; Women?s Specialty Services) Criteria: As detailed by 2 CFR 200.402, the total cost of a Federal award is the sum of the allowable direct and allocable indirect costs less any applicable credits. Condition: During testing of amounts charged to the grants it was noted that provider stabilization payments were charged to the Treatment and Women?s Specialty Services grants but were not authorized by the grants. Cause/Effect: This condition appears to be the result of a misunderstanding of costs allowed under this grant. These costs were not in compliance with 2 CFR 200.402. Questioned Cost: $289,629 (Treatment and Access Management: $275,928, Women?s Specialty Services: $13,701). Recommendation: We recommend that the Entity review all grant agreements to gain a thorough understanding of allowable costs and then establish/modify internal controls to assure that only allowable costs are charged to the grant. View of Responsible Official: Management is in agreement with this recommendation
April 13, 2023 Roslund, Prestage & Company, P.C. 525 W. Warwick Drive, Suite A Alma, MI 48801 Finding: 2022-001: Significant deficiency in internal control / immaterial non-compliance Federal Program: Block Grants for Prevention and Treatment of Substance Abuse ? Treatment and Women?s Specialty Services Condition: During testing of amounts charged to the grants, it was noted that provider stabilization payments were charged to the Treatment and Women?s Specialty Services grants but were not authorized by the grants. Corrective Action Plan: Mid-State Health Network will review grant documents when implementing new funding initiatives and will seek guidance from the awarding agency as needed. Responsible Party: Amy Keinath, Finance Manager Anticipated Completion Date: October 1, 2022
FAC accepted this audit on April 7, 2022 — management decision was due October 7, 2022.
FAC accepted this audit on May 15, 2021 — management decision was due November 15, 2021.
FAC accepted this audit on June 18, 2020 — management decision was due December 18, 2020.
During testing of contracts with subrecipients it was noted that these contracts did not include portions of required disclosures. Cause/Effect: This condition appears to be the result of inadequate internal controls over compliance. Contracts with subrecipients were not in compliance with 2 CFR 200.331. Questioned Cost: None. Recommendation: We recommend that the Entity update all contracts with subrecipients to include required language. View of Responsible Official: Management is in agreement with this recommendation
Show full finding ▾Hide full finding ▴2019-001: Considered a significant deficiency in internal control over compliance Program: CFDA #93.788 Opioid STR Criteria: As detailed by 2 CFR 200.331, the pass-through entity must communicate specific information to subrecipients, as applicable. Condition: During testing of contracts with subrecipients it was noted that these contracts did not include portions of required disclosures. Cause/Effect: This condition appears to be the result of inadequate internal controls over compliance. Contracts with subrecipients were not in compliance with 2 CFR 200.331. Questioned Cost: None. Recommendation: We recommend that the Entity update all contracts with subrecipients to include required language. View of Responsible Official: Management is in agreement with this recommendation
June 17, 2020 Roslund Prestage & Company, PC 525 W. Warwick Drive, Suite A Alma, MI 48601 In response to Section III ? Federal Award Findings and Questioned Costs, MSHN will implement the following Corrective Action Plan (CAP): Finding: As detailed by 2 CFR 200.331, the pass-through entity must communicate specific information to subrecipients, as applicable. Corrective Action ? This finding is related to Sub-recipient disclosures including but not limited to Catalog of Federal Domestic Assistance (CFDA) number notifications for awardees. For Fiscal Year 2020, MSHN will send letters (intended to be an attachment to their contract) to State Targeted Response subrecipients containing CFDA number and total allocation amount. In addition, State Opioid Response subrecipients will receive a letter (intended to be an attachment to their contract) containing CFDA number and a general statement describing how funding amounts are allocated. Beginning in Fiscal Year 2021, MSHN will update boiler plate language to address how grant funds are allocated. The Block Grant CFDA number will remain in the cover letter and other grants will be added as a separate attachment containing the CFDA number and any other necessary disclosures. MSHN?s Finance Manager will review 2 CFR 200 disclosure language annually to ensure contracts contain appropriate disclosures to the extent possible. Responsible Party: Amy Keinath, Finance Manager Completion Date: July 31, 2020 Please contact me at 517.253.7546 if you have questions.
FAC accepted this audit on March 26, 2019 — management decision was due September 26, 2019.
FAC accepted this audit on June 7, 2018 — management decision was due December 7, 2018.
GSA_MIGRATION
Show full finding ▾Hide full finding ▴GSA_MIGRATION
GSA_MIGRATION
FAC accepted this audit on May 15, 2017 — management decision was due November 15, 2017.
Data source: This information comes from the Federal Audit Clearinghouse, the official repository of Single Audit data. All data is public domain. Verify this organization's audit history at fac.gov.
Browse other Single Audit organizations in Michigan →
Track your findings and corrective action plans across audit cycles.
Start tracking findings →Add it to a monitored group and get alerted when a new audit, finding, repeat finding, or management-decision deadline shows up — instead of checking back.
Checking several at once? Portfolio view →
© 2026 Single Audit Intelligence. All data is public domain.
